BackAdc Therapeutics SA Overview

Adc Therapeutics SA Cost of Revenue

Cost of Revenue analysis for ADCT.

Quarterly Cost of Revenue

$3.62M
75.4% YoY

As of Mar 31, 2026

Annual Cost of Revenue (TTM)

$9.23M
45.6% YoY

Trailing 12 months ending Mar 31, 2026

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)